Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study.
about
Extent of lymphadenectomy in radical cystectomy for bladder cancer.Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tractCurrent Status of Robot-Assisted Radical Cystectomy: What is the Real Benefit?Extended vs non-extended pelvic lymph node dissection and their influence on recurrence-free survival in patients undergoing radical cystectomy for bladder cancer: a systematic review and meta-analysis of comparative studiesMultimodal management of muscle-invasive bladder cancerBeyond penile cancer, is there a role for sentinel node biopsy in urological malignancies?Radical transurethral resection alone, robotic or partial cystectomy, or extended lymphadenectomy: can we select patients with muscle invasion for less or more surgery?MiRNA-141 and miRNA-200b are closely related to invasive ability and considered as decision-making biomarkers for the extent of PLND during cystectomyAssessing urology and nephrology research activity in Arab countries using ISI web of science bibliometric databaseRadical cystectomy: do we need standardization?Bladder cancer: narrowing the gap between evidence and practiceLymph node-positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity.Role of pelvic lymphadenectomy in the treatment of bladder cancer: a mini review.Pelvic lymph nodes: distribution and nodal tumour burden of urothelial bladder cancerOptimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging.Pelvic lymph node dissection and outcome of robot-assisted radical cystectomy for bladder carcinoma.Pelvic lymphadenectomy in the treatment of invasive bladder cancer: literature review.Does skip metastasis or other lymph node parameters have additional effects on survival of patients undergoing radical cystectomy for bladder cancer?Histological variant as the significant predictor of survival in patients with lymph node positive urothelial carcinoma of the bladder.Treatment of invasive bladder cancer: lessons from the past and perspective for the future.The importance of an extended lymphadenectomy in the management of high-grade invasive bladder cancer.Extended pelvic lymph node dissection: before or after radical cystectomy? A multicenter study of the Turkish society of urooncologyRecent advances in the treatment of bladder cancer.Lymphadenectomy for invasive bladder cancer: I. historical perspective and contemporary rationale.Lymphadenectomy for invasive bladder cancer. II. technical aspects and prognostic factors.Clinical outcome after cystectomy in patients with lymph node-positive bladder cancer.A fourteen-year review of radical cystectomy for transitional cell carcinoma demonstrating the usefulness of the concept of lymph node density.Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light.Prostate-sparing cystectomy: has Pandora's box been opened?Improving the prognosis of patients after radical cystectomy. Part I: the role of lymph node dissection.Prostatic transitional cell carcinoma: pathologic features and clinical management.Pelvic Lymph Node Dissection may be Limited on the Contralateral Side in Strictly Unilateral Bladder Cancer without Compromising Oncological RadicalityBenefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy.Predicting survival after radical cystectomy for bladder cancer.Radical cystectomy for bladder cancer: A single center experience.Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer.Clinical significance of lymph node dissection in patients with muscle-invasive upper urinary tract transitional cell carcinoma treated with nephroureterectomy.Role of lymphadenectomy for invasive bladder cancer.Lymph node dissection for bladder cancer: the issue of extent and feasibility in the minimally invasive era.Adjuvant and neoadjuvant radiotherapy for bladder cancer: revisited.
P2860
Q24814634-19C25A50-482D-4ABA-B823-3B5CFD5E077DQ26775097-AD72D234-4327-4B9B-865A-609B6C58040CQ26779973-7FADE6DF-53D0-4317-BC8F-FC50280C7460Q26864095-3296B8D8-A605-4054-8B0B-04232A88B119Q27011624-837D6F29-2F0F-4F42-83E5-8FA5843DED32Q28079221-DB62C08A-CD0C-4EC5-8129-DDBDD58BC560Q28084159-F6CBCB77-E86E-4DE6-9503-239698C1FE30Q28389318-B783392A-E276-418B-8419-8E984CA2D913Q28658233-75DB42DB-5A11-432A-B839-5BDB35BE42DAQ30240141-76832216-4ABF-4147-AAEF-38F2BF2FDD84Q30362052-4784D557-E8BD-4C65-9C48-26CB39FCBA23Q33669763-2C453545-B8EB-4CDE-B0AC-22DF4C1AAEFCQ33931385-AE448A15-0A10-42E5-9451-1FD9756D4AECQ34308357-F384E985-D918-42A7-B60D-18CB27B3A592Q34458231-37824E1E-282F-42B4-8B09-34FBB6F2440DQ34585907-C869358D-BE94-4AEF-9ACF-EDEE04DAEF6AQ35195109-6AB50167-227A-44DB-B4AD-2FDAEF1F46A1Q35590489-D324C2DE-0FD8-41F6-8833-381EB69C8B6AQ35592277-5B544908-8F44-471F-B093-0B11628F5C95Q35873130-3364209B-9A3A-41FF-96A0-95359D8FBD4EQ35987743-82D97A88-A935-4D1B-A88E-ED6016F559D8Q36120392-E7C9F42C-BCDC-45A5-B45F-06119DB8871CQ36334892-6B4039EF-BFC9-41F9-8D1D-117E9E7EE5DBQ36375410-2E71420F-2397-40C2-B3FC-C728D3E40A9BQ36375415-B5C2CCAA-56D3-4025-8E69-9B7D92034AFCQ36500533-47C2CE7A-9B17-4E7E-A1C6-0727BF3A5A01Q36642888-7D2CD3C3-6DCC-49AF-93E6-A66D5BD326E9Q36660200-E224533E-ED11-48C1-A968-6A2C9BB98067Q36879159-DF4FED8D-4C96-4F99-B393-94055D764384Q36990721-603EDAD9-EBCB-476E-97FE-BCF45D1F141BQ37008876-EA3B4F17-4429-47E6-9D95-FA8A59480E83Q37053765-F807B16D-65BC-4989-8370-9DEDCF9BF023Q37053991-D571F5A7-4EBD-47FE-9A36-DFC7C4895740Q37103989-0EAC1E5B-DF7C-43DE-A1D4-1916C6494E41Q37197485-C8AA7AD6-3183-465D-A491-BE015B16D50BQ37202768-402DB543-7CA1-4DA8-A4C3-1AB4A79932E1Q37284763-7F69EACD-EB34-46CD-BF97-2DFC92D0A7CDQ37472544-01E96A3B-AC7E-4042-9AD5-14520CBF2EA4Q37642789-E2FE9D45-8818-436E-A6BD-AC02E7E4E202Q37771961-F8308E93-E25A-4C90-9574-2347058EAE3E
P2860
Extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Extended radical lymphadenecto ...... prospective multicenter study.
@en
type
label
Extended radical lymphadenecto ...... prospective multicenter study.
@en
prefLabel
Extended radical lymphadenecto ...... prospective multicenter study.
@en
P2093
P1476
Extended radical lymphadenecto ...... prospective multicenter study.
@en
P2093
Abol-Enein H
Allhoff EP
Franzaring L
Ghoneim MA
Hohenfellner R
Kastendieck H
Leissner J
P304
P356
10.1097/01.JU.0000102302.26806.FB
P407
P577
2004-01-01T00:00:00Z